Galapagos NV
GLPG
#5074
Rank
HK$14.60 B
Marketcap
HK$217.42
Share price
0.00%
Change (1 day)
-15.50%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of March 2026 : HK$58.39 Million

According to Galapagos NV's latest financial reports the company's total debt is HK$58.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2024-12-31HK$94.69 M14.3%
2023-12-31HK$82.84 M-54.86%
2022-12-31HK$0.18 B-22.61%
2021-12-31HK$0.23 B-15.49%
2020-12-31HK$0.28 B26.74%
2019-12-31HK$0.22 B
2018-12-31N/A-100%
2017-12-31HK$0.08 M-83.58%
2016-12-31HK$0.51 M-47.27%
2015-12-31HK$0.97 M-38.14%
2014-12-31HK$1.57 M-62.57%
2013-12-31HK$4.2 M1.35%
2012-12-31HK$4.15 M-53%
2011-12-31HK$8.83 M-31.44%
2010-12-31HK$12.88 M-21.83%
2009-12-31HK$16.48 M-9.49%
2008-12-31HK$18.21 M-63.37%
2007-12-31HK$49.72 M-37.61%
2006-12-31HK$79.7 M8.93%
2005-12-31HK$73.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.12 B 738,178.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$266.94 B 457,029.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$571.24 B 978,122.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$181.68 B 311,026.48%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$385.10 B 659,365.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$265.93 B 455,297.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$197.86 B 338,734.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
HK$0.42 B 620.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.55 B 226,900.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel